Global Compound Liquorice Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Compound Liquorice Market Research Report 2024
It can make people addicted. It is brown or brown in appearance. It smells strong, tastes sweet and is easy to get damp. It is a good antitussive and expectorant medicine. It has good effect in dealing with cough. It also has bacteriostasis and anti-inflammatory effect. It can be used to treat frequent, severe dry cough and phlegm-free dry cough.
According to Mr Accuracy reports’s new survey, global Compound Liquorice market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Compound Liquorice market research.
Key manufacturers engaged in the Compound Liquorice industry include Inner Mongolia Lantai Pharmaceutical, Tianjin Lisheng Pharmaceutical, Tianjin Huajin Pharmaceutical Factory, Beijing Shuanghe Pharmaceutical, Tongji Hall, Sinopharm Weiqida Pharmaceutical, Harbin Taihua Pharmaceutical, Xiuzheng Pharmaceutical Group and Jiangxi Tianshikang, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Compound Liquorice were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Compound Liquorice market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Compound Liquorice market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Inner Mongolia Lantai Pharmaceutical
Tianjin Lisheng Pharmaceutical
Tianjin Huajin Pharmaceutical Factory
Beijing Shuanghe Pharmaceutical
Tongji Hall
Sinopharm Weiqida Pharmaceutical
Harbin Taihua Pharmaceutical
Xiuzheng Pharmaceutical Group
Jiangxi Tianshikang
Sichuan Emeishan Pharmaceutical
Guizhou Yibai Pharmaceutical
Zhonglian Pharmaceutical
Guangxi Nanning Baihui Pharmaceutical
Tsumura & Co.
Segment by Type
Tablets
Mixtures
Other
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Compound Liquorice report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Compound Liquorice market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Compound Liquorice market research.
Key manufacturers engaged in the Compound Liquorice industry include Inner Mongolia Lantai Pharmaceutical, Tianjin Lisheng Pharmaceutical, Tianjin Huajin Pharmaceutical Factory, Beijing Shuanghe Pharmaceutical, Tongji Hall, Sinopharm Weiqida Pharmaceutical, Harbin Taihua Pharmaceutical, Xiuzheng Pharmaceutical Group and Jiangxi Tianshikang, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Compound Liquorice were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Compound Liquorice market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Compound Liquorice market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Inner Mongolia Lantai Pharmaceutical
Tianjin Lisheng Pharmaceutical
Tianjin Huajin Pharmaceutical Factory
Beijing Shuanghe Pharmaceutical
Tongji Hall
Sinopharm Weiqida Pharmaceutical
Harbin Taihua Pharmaceutical
Xiuzheng Pharmaceutical Group
Jiangxi Tianshikang
Sichuan Emeishan Pharmaceutical
Guizhou Yibai Pharmaceutical
Zhonglian Pharmaceutical
Guangxi Nanning Baihui Pharmaceutical
Tsumura & Co.
Segment by Type
Tablets
Mixtures
Other
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Compound Liquorice report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source